Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey

Basit Öğe Kaydı
dc.authorid0000-0001-9656-131Xen_US
dc.contributor.authorŞen, Elif
dc.contributor.authorGüçlü, Salih Zeki
dc.contributor.authorKibar, Işıl
dc.contributor.authorÖcal, Ülkü
dc.contributor.authorYılmaz, Veysel
dc.contributor.authorÇelik, Onur
dc.contributor.authorÇimen, Filiz
dc.contributor.authorTopçu, Füsun
dc.contributor.authorOrhun, Meltem
dc.date.accessioned2024-04-02T08:10:23Z
dc.date.available2024-04-02T08:10:23Z
dc.date.issued2015en_US
dc.departmentDicle Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Göğüs Hastalıkları Ana Bilim Dalıen_US
dc.description.abstractBackground: Low adherence to Global initiative for chronic Obstructive Lung Disease (GOLD) guideline recommendations has been reported worldwide. There has been no study on the adherence to GOLD guidelines for COPD treatment in Turkey. Objectives: To investigate the rates of adherence to GOLD 2010 guidelines for COPD treatment among pulmonologists. Design: A multi-center, cross-sectional, observational study was carried out in eleven pulmonary outpatient clinics across Turkey. Adherence to GOLD was evaluated through hospital records. Demographic and clinical data were recorded. Results: Study included 719 patients (mean age: 62.9±9.7 years; males 85.4%) of whom 16 was classified as GOLD Stage I, 238 as II, 346 as III, and 119 as IV, and only 59.5% received appropriate treatment. Rates of guideline adherence varied across GOLD stages (I, 6.3%; II, 14.7%; III, 84.4%; and IV, 84%). Causes of inappropriate therapies were overtreatment (Stage I, 100% and Stage II, 91.1%), undertreatment (Stage III, 3.3% and Stage IV, 10.9%) and lack of treatment (Stage II, 3.8%; Stage III, 2.3%; and Stage IV, 5.9%). The most preferred regimen (43.4%) was long-acting β2-agonist-inhaled corticosteroid-long-acting muscarinic antagonist. Overall, 614 patients (89%) received treatment containing inhaled corticosteroid. Conclusion: Pulmonologists in Turkey have low rates of adherence to GOLD guidelines in COPD treatment. Inappropriateness of therapies was due to overtreatment in early stages and excessive use of inhaled corticosteroid (ICS) in all disease stages.en_US
dc.identifier.citationŞen, E., Güçlü, S. Z., Kibar, I., Öcal, Ü., Yılmaz, V., Çelik, O., ve diğerleri. (2015). Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey. International Journal of COPD, 10(1), 2657-2663.en_US
dc.identifier.doi10.2147/COPD.S85324
dc.identifier.endpage2663en_US
dc.identifier.issn1176-9106
dc.identifier.issue1en_US
dc.identifier.pmid26715844
dc.identifier.scopus2-s2.0-84949979821
dc.identifier.scopusqualityQ1
dc.identifier.startpage2657en_US
dc.identifier.urihttps://www.dovepress.com/getfile.php?fileID=28341
dc.identifier.urihttps://hdl.handle.net/11468/13792
dc.identifier.volume10en_US
dc.identifier.wosWOS:000366558000001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorTopçu, Füsun
dc.language.isoenen_US
dc.publisherDove Medical Press Ltd.en_US
dc.relation.ispartofInternational Journal of COPD
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAdherenceen_US
dc.subjectCOPDen_US
dc.subjectGlobal initiative for chronic obstructive lung disease guidelinesen_US
dc.subjectInhaled corticosteroiden_US
dc.subjectOvertreatmenten_US
dc.subjectTreatment approachen_US
dc.subjectTurkeyen_US
dc.titleAdherence to GOLD guideline treatment recommendations among pulmonologists in Turkeyen_US
dc.titleAdherence to GOLD guideline treatment recommendations among pulmonologists in Turkey
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.pdf
Boyut:
317.36 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
[ X ]
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Dahili Tıp Bilimleri Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu